{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:31:02Z","timestamp":1791930662140,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011841","name":"Xinxiang Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242102310475"],"award-info":[{"award-number":["242102310475"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242102310365"],"award-info":[{"award-number":["242102310365"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejphar.2025.177457","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T23:11:22Z","timestamp":1741302682000},"page":"177457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Erythromycin repurposing for hepatocellular carcinoma treatment: Targeting CD24 to enhance anti-tumor immunity"],"prefix":"10.1016","volume":"998","author":[{"given":"Mingguang","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiesuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangle","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-0198","authenticated-orcid":false,"given":"Huijie","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177457_bib1","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Amira A","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177457_bib2","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Chayanon","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2025.177457_bib3","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Chen","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177457_bib4","article-title":"Erythromycin","volume":"71","author":"D","year":"1987","journal-title":"Med. Clin."},{"key":"10.1016\/j.ejphar.2025.177457_bib5","article-title":"Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology","volume":"20","author":"Daniel","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177457_bib6","article-title":"Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Chinese perspective","volume":"29","author":"Diyang","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177457_bib7","article-title":"Ribosome-binding and anti-microbial studies of the mycinamicins, 16-membered macrolide antibiotics from Micromonospora griseorubida","volume":"49","author":"Elinor","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177457_bib8","article-title":"Antigen cross-presentation by macrophages","volume":"11","author":"Elke M","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177457_bib9","article-title":"CD24 expression is a new prognostic marker in breast cancer","volume":"9","author":"Glen","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177457_bib10","article-title":"M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages","volume":"278","author":"Gowri Rangaswamy","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejphar.2025.177457_bib11","article-title":"Macrophages: their Untold story in T cell activation and function","volume":"342","author":"Jennifer","year":"2019","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.177457_bib12","article-title":"LncRNA IL21-AS1 facilitates tumour progression by enhancing CD24-induced phagocytosis inhibition and tumorigenesis in ovarian cancer","volume":"15","author":"Jie","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.177457_bib13","article-title":"Macrolide and Ketolide antibiotics inhibit the cytotoxic effect of trastuzumab emtansine in HER2-positive breast cancer cells: Implication of a potential drug-ADC interaction in cancer chemotherapy","volume":"20","author":"Keisuke","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejphar.2025.177457_bib14","article-title":"Nano-LYTACs for degradation of membrane proteins and inhibition of CD24\/Siglec-10 signaling pathway","volume":"10","author":"Kun","year":"2023","journal-title":"Adv. Sci.(Weinh)"},{"key":"10.1016\/j.ejphar.2025.177457_bib15","article-title":"Context-specific action of macrolide antibiotics on the eukaryotic ribosome","volume":"12","author":"Maxim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177457_bib16","article-title":"Erythromycin promotes monocyte to macrophage differentiation","volume":"47","author":"N","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejphar.2025.177457_bib17","article-title":"Azithromycin, a potent autophagy inhibitor for cancer therapy, perturbs cytoskeletal protein dynamics","volume":"128","author":"Naoharu","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2025.177457_bib18","article-title":"From monocytes to M1\/M2 macrophages: phenotypical vs. Functional differentiation","volume":"5","author":"Paola","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177457_bib19","article-title":"CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma","volume":"9","author":"Shuai","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.177457_bib20","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Soichiro","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejphar.2025.177457_bib21","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Sudeep","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2025.177457_bib22","article-title":"Overview of CD24 as a new molecular marker in ovarian cancer","volume":"234","author":"Vahideh","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2025.177457_bib23","article-title":"Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma","volume":"11","author":"Weijian","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.ejphar.2025.177457_bib24","article-title":"Precision treatment in advanced hepatocellular carcinoma","volume":"42","author":"Xupeng","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2025.177457_bib25","article-title":"Emerging phagocytosis checkpoints in cancer immunotherapy","volume":"8","author":"Yu'e","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177457_bib26","first-page":"1519","article-title":"Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model","volume":"11","author":"Yuji","year":"2024","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejphar.2025.177457_bib27","article-title":"Baicalein inhibits hepatocellular carcinoma cells through suppressing the expression of CD24","volume":"29","author":"Zhengquan","year":"2015","journal-title":"Int. Immunopharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925002110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925002110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:31:35Z","timestamp":1762144295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925002110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":27,"alternative-id":["S0014299925002110"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177457","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythromycin repurposing for hepatocellular carcinoma treatment: Targeting CD24 to enhance anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177457"}}